Rapid Evolution of Ionic Silver Resistance in Escherichia Phage T7
Microorganisms · 01.06.2026 · 14 (6) · 1243
DOI: 10.3390/microorganisms14061243 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 01.06.2026. Verfasst von Larisa Chila Kiki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, North Carolina A&T State University, 1601 E Market Street, Greensboro, NC 27411, USA. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. National Science Foundation.
Abstract (Originalsprache)
The antimicrobial resistance crisis has led to the use of metals and bacteriophages as possible alternatives to antibiotics. Experimental studies have examined interactions between ionic/nano-silver and bacteriophages against multidrug-resistant bacteria. However, these approaches have often failed to examine whether silver affects the stability and infectivity of bacteriophages. Here, we utilized experimental evolution to evolve resistance to ionic silver in bacteriophage T7. High ionic silver concentrations that do not represent physiological exposure conditions were used to impose strong selective pressure. Evolution of ionic silver resistance in phage T7 was rapid, as evidenced by recovery of bacteriophage growth in E. coli following repeated exposures to ionic silver, enhanced infectivity of silver-selected populations relative to parallel control and ancestral populations under increasing ionic silver concentrations, and greater suppression of E. coli growth in standard medium. Furthermore, silver resistance evolved without loss of thermal or pH stability under the conditions tested. The genomic foundation of silver resistance was relatively simple, with positive and negative natural selection differentiating the silver-selected populations from the controls and ancestral populations across serial passages in silver. Support for replication-associated adaptation under ionic silver selection may be reflected in recurrent mutations identified in genes involved in transcription, DNA replication, and genome maintenance, including T7p07 (RNA polymerase), T7p10 (DNA ligase), and T7p29 (DNA polymerase I). These findings highlight the importance of evaluating phage –silver combination strategies within an evolutionary framework that accounts for the adaptive capacity of bacteriophages under silver selection.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biology, North Carolina A&T State University, 1601 E Market Street, Greensboro, NC 27411, USA.
- Department of Biotechnology, Alamance Community College, 1247 Jimmie Kerr Rd, Graham, NC 27253, USA.
- Department of Biology, Biochemistry, Public Health, Quality Science, Earlham College, 801 National Road West, Richmond, IN 47374, USA.
- Department of Biological Sciences, Winston-Salem State University, 601 S Martin Luther King Jr. Drive, Winston Salem, NC 27110, USA.
ORCID-Profile: Larisa Chila Kiki, Monela Ntonifor, Ugonna Morikwe, Franklin Ezeanowai, Akamu Ewunkem, Joseph Graves, Liesl Jeffers-Francis
Förderung
- U.S. National Science Foundation
Zitieren
APA
Kiki, L. C., Ntonifor, M., LaDelle, W., Morikwe, U., Ezeanowai, F., McGee, L., Ewunkem, A., Graves, J., & Jeffers-Francis, L. (2026). Rapid Evolution of Ionic Silver Resistance in Escherichia Phage T7. Microorganisms, 14(6), 1243. https://doi.org/10.3390/microorganisms14061243
Vancouver
Kiki LC, Ntonifor M, LaDelle W, Morikwe U, Ezeanowai F, McGee L, et al. Rapid Evolution of Ionic Silver Resistance in Escherichia Phage T7. Microorganisms. 2026;14(6):1243. doi:10.3390/microorganisms14061243
BibTeX
@article{Kiki2026,
author = {Kiki, Larisa Chila and Ntonifor, Monela and LaDelle, Walter and Morikwe, Ugonna and Ezeanowai, Franklin and McGee, Lindsey and Ewunkem, Akamu and Graves, Joseph and Jeffers-Francis, Liesl},
title = {Rapid Evolution of Ionic Silver Resistance in Escherichia Phage T7},
journal = {Microorganisms},
year = {2026},
volume = {14},
number = {6},
pages = {1243},
doi = {10.3390/microorganisms14061243}
}
EUVIMED